Tikoo, K., Kumar, P., & Gupta, J. (2009). Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats. BioMed Central.
Chicago Style aipamenaTikoo, Kulbhushan, Parveen Kumar, and Jeena Gupta. Rosiglitazone Synergizes Anticancer Activity of Cisplatin and Reduces Its Nephrotoxicity in 7, 12-dimethyl Benz{a}anthracene (DMBA) Induced Breast Cancer Rats. BioMed Central, 2009.
MLA aipamenaTikoo, Kulbhushan, Parveen Kumar, and Jeena Gupta. Rosiglitazone Synergizes Anticancer Activity of Cisplatin and Reduces Its Nephrotoxicity in 7, 12-dimethyl Benz{a}anthracene (DMBA) Induced Breast Cancer Rats. BioMed Central, 2009.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.